文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

A study demonstrating users' preference for the adapted-REQUITE patient-reported outcome questionnaire over PRO-CTCAE in patients with lung cancer.

作者信息

Jordan Thomas, Nuamek Thitikorn, Fornacon-Wood Isabella, Califano Raffaele, Coote Joanna, Harris Margaret, Mistry Hitesh, Taylor Paul, Woolf David, Faivre-Finn Corinne

机构信息

Division of Cancer Sciences, Faculty of Biology, Medicine, and Health, University of Manchester, Manchester, United Kingdom.

The Christie NHS Foundation Trust, Manchester, United Kingdom.

出版信息

Front Oncol. 2024 Apr 10;14:1328871. doi: 10.3389/fonc.2024.1328871. eCollection 2024.


DOI:10.3389/fonc.2024.1328871
PMID:38660130
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11039780/
Abstract

INTRODUCTION: The use of patient-reported outcomes (PROs) has been shown to enhance the accuracy of symptom collection and improve overall survival and quality of life. This is the first study comparing concordance and patient preference for two PRO tools: Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) and the adapted-REQUITE Lung Questionnaire. MATERIALS AND METHODS: Patients with lung cancer were recruited to the study while attending outpatient clinics at a tertiary cancer centre. Clinician-reported outcomes were generated through initial patient assessment with CTCAE v4.03. Participants then completed the PRO-CTCAE and adapted-REQUITE questionnaires. Concordance between the 2 questionnaires was assessed by calculating Pearson correlation coefficient. PRO-CTCAE and CTCAE concordance was demonstrated by calculating Pearson correlation coefficient from the linear predictors of an ordinal logistic regression. P-values were also calculated. RESULTS: Out of 74 patients approached, 65 provided written informed consent to participate in the study. 63 (96.9%) patients completed both PRO-CTCAE and adapted-REQUITE questionnaires. Pearson correlation coefficient between PRO tools was 0.8-0.83 (p <.001). Correlation between CTCAE and PRO-CTCAE ranged between 0.66-0.82 (p <.001). Adapted-REQUITE and CTCAE correlation was higher for all symptoms ranging between 0.79-0.91 (p <.001). Acceptable discrepancies within one grade were present in 96.8%-100% of symptom domains for REQUITE and in 92.1%-96.8% for all domains in the PRO-CTCAE. 54% of the total participant cohort favored the adapted-REQUITE questionnaire due to reduced subjectivity in the questions and ease of use. CONCLUSION: The adapted-REQUITE questionnaire has shown a superior correlation to clinician-reported outcomes and higher patient preference than the PRO-CTCAE. The results of this study suggest the use of the REQUITE questionnaire for patients with lung cancer in routine clinical practice.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/441f/11039780/9fd380594d18/fonc-14-1328871-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/441f/11039780/9fd380594d18/fonc-14-1328871-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/441f/11039780/9fd380594d18/fonc-14-1328871-g001.jpg

相似文献

[1]
A study demonstrating users' preference for the adapted-REQUITE patient-reported outcome questionnaire over PRO-CTCAE in patients with lung cancer.

Front Oncol. 2024-4-10

[2]
Feasibility and acceptability of electronic symptom surveillance with clinician feedback using the Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Danish prostate cancer patients.

J Patient Rep Outcomes. 2017

[3]
Acceptability of Routine Evaluations Using Patient-Reported Outcomes of Common Terminology Criteria for Adverse Events and Other Patient-Reported Symptom Outcome Tools in Cancer Outpatients: Princess Margaret Cancer Centre Experience.

Oncologist. 2019-8-13

[4]
The Japanese version of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE): psychometric validation and discordance between clinician and patient assessments of adverse events.

J Patient Rep Outcomes. 2017

[5]
Reliability and Validity of the Korean Language Version of the U.S. National Cancer Institute's Patient-Reported Outcomes Common Terminology Criteria for Adverse Events.

J Pain Symptom Manage. 2020-5

[6]
Cultural adaptation of the Italian version of the Patient-Reported Outcomes Common Terminology Criteria for Adverse Event (PRO-CTCAE®).

Tumori. 2023-6

[7]
Using Patient-Reported Outcomes to Describe the Patient Experience on Phase I Clinical Trials.

JNCI Cancer Spectr. 2020-8-14

[8]
Selecting a Subset Based on the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events for Patient-Reported Symptom Monitoring in Lung Cancer Treatment: Mixed Methods Study.

JMIR Cancer. 2021-9-14

[9]
Stakeholder perspectives on implementing the National Cancer Institute's patient-reported outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).

Transl Behav Med. 2011-3

[10]
Evaluating the use of the EORTC patient-reported outcome measures for improving inter-rater reliability of CTCAE ratings in a mixed population of cancer patients: study protocol for a randomized controlled trial.

Trials. 2020-10-13

引用本文的文献

[1]
Integrating Electronic Patient-Reported Outcome Measures (ePROMs) into Personalised Follow-up for Patients after Radiotherapy. A Feasibility Study.

Tech Innov Patient Support Radiat Oncol. 2025-8-7

[2]
Mapping immune checkpoint inhibitor side effects to item libraries for use in real-time side effect monitoring systems.

J Patient Rep Outcomes. 2025-3-6

[3]
Chemotoxicity and Associated Risk Factors in Colorectal Cancer: A Systematic Review and Meta-Analysis.

Cancers (Basel). 2024-7-20

本文引用的文献

[1]
Patient and clinician-reported experiences of using electronic patient reported outcome measures (ePROMs) as part of routine cancer care.

J Patient Rep Outcomes. 2023-5-4

[2]
Experience With the Routine Use of Electronic Patient-Reported Outcome Measures for Patients With Lung Cancer.

JCO Clin Cancer Inform. 2023-4

[3]
Symptom Trajectories Informing Patient Care After Lung Cancer Surgery: A Longitudinal Patient-Reported Outcome Study.

Ann Surg Oncol. 2023-5

[4]
Profiling symptom burden and its influencing factors at discharge for patients undergoing lung cancer surgery: a cross-sectional analysis.

J Cardiothorac Surg. 2022-9-3

[5]
Stepping into the real world: a mixed-methods evaluation of the implementation of electronic patient reported outcomes in routine lung cancer care.

J Patient Rep Outcomes. 2022-6-20

[6]
The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline.

Ann Oncol. 2022-9

[7]
Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study).

Lung Cancer. 2022-4

[8]
A Short Report Examining the Introduction of Routine Use of Patient-Reported Outcome Measures in a Mixed Oncology Population.

Clin Oncol (R Coll Radiol). 2022-4

[9]
Electronic Patient-Reported Outcome Measures for Monitoring of Patients on Cancer Treatment Can Reduce the Need for Face-To-Face Hospital Visits: A Tertiary UK Oncology Centre Experience.

Clin Oncol (R Coll Radiol). 2022-1

[10]
Discrepancy in the perception of symptoms among patients and healthcare providers after lung cancer surgery.

Support Care Cancer. 2022-2

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索